The chemical structure of bardoxolone methyl. | Download Scientific Diagram
Bardoxolone Methyl | ≥99%(HPLC) | Selleck | IκB/IKK inhibitor
Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology
Frontiers | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages
Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
Reata Pharmaceuticals Inc. - Our Science - Our Technologies - Nrf2 Activators
APExBIO - Bardoxolone methyl|IKK inhibitor, potent antioxidant inflammation modulator|CAS# 218600-53-4
Increased albuminuria in bardoxolone methyl–treated type 2 diabetes patients: mere reflection of eGFR improvement? - Kidney International
Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Imp
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 - Kidney International Reports
Bardoxolone methyl (RTA 402) | ≥99%(HPLC) | IκB/IKK inhibitor | AdooQ®
Bardoxolone Methyl | ≥99%(HPLC) | Selleck | IκB/IKK inhibitor
Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer | HTML
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Targeting crosstalk between Nrf-2, NF-κB and androgen receptor signaling in prostate cancer
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes | NEJM
BARDOXOLONE METHYL
Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology
Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology
